Upregulated CXCL5 in patients with cervical cancer increases the oncogenic potential of HeLa cervical cancer cells by increasing the phosphorylation of ERK1/2 and Akt and the gene expression of CXCR2 [36]. The gene discussed is CXCR2; the disease is cervical carcinoma.